Genelux Investor Presentation Deck slide image

Genelux Investor Presentation Deck

Choice Platform Library: 500+ Vectors with 110+ Transgenes Therapeutic Genes Immune Modularity Therapeutic Antibodies GENELUX Engineered and selected clonal isolated (non-GMO) viral strains identified from in vitro and in vivo selection criteria Virus-encoded transgenes Cell Growth & Differentiation Regulators Metastasis Suppressor Genes Cell Matrix Degradative Genes Immune Regulators Superantigens Cytokines/Chemokines Single-chain Antibodies Hormones ✓ In vitro & in vivo tested: GLP Tox ready Immune Modularity Molecules IL-6/SIL-6R O O IL-24 Cell Growth & Differentiation Regulators OBMP-4 Cell Matrix-Degradative Genes OhMMP9 Clonal Isolated Strains (non-GMO) o V-VETI (LIVP6.1.1) o Cop15.1.1 O LIVP1.1.1 O LIVP5.1.1 Single-Chain Antibodies o Anti-VEGF Anti-DLL4 Anti-CTLA4 o Anti-PD-1 o Anti-FAP o Anti-PD-L1 o Anti-avẞ3- integrin 27
View entire presentation